Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer

ABSTRACT: This study seeks to use Cabozantinib to treat those with Metastatic Colorectal Cancer who have not previously responded to treatment.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2274289 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR